Job Description Summary Bringing life-changing medicines to millions of people, Novartis sits at the intersection of cutting-edge medical science and innovative digital technology. As a global company, the resources and opportunities for growth and development are plentiful including global and local cross functional careers, a diverse learning suite of thousands of programs & an in-house marketplace for rotations & project work. With strong medicines pipeline our current transformation will not just deliver growth for our business but continue to allow us to bring innovative medicines to patients quickly.Job DescriptionAbout the roleOur ambition is to be leaders in immunology across international markets and, Remibrutinib is at the core and center being a prioritized launch for the organization.The Executive Director International, Remibrutinib, plays a pivotal role in leading the end-to-end brand strategy, encompassing the vision, development, orchestration, implementation, and evaluation of integrated Remibrutinib strategies across major international markets. As an enterprise leader, the ED will focus on the top three countries (Germany, Japan, and China) and Regions, driving the successful launch and growth of Remibrutinib, leading the launch of Hidradenitis Suppurative (HS) and supporting the launch of CSU among other LCMs.The incumbent will collaborate closely with Global Drug Development (GDD), International Medical Affairs, Value & Access, and Customer & Market Activation teams to drive consistent strategy development and execution. This role represents the commercial team across different instances of the organization.Key Responsibilities

• International Launch Strategy: Lead the development and implementation of the launch plan for the assigned indication, ensuring alignment with overall asset strategy and corporate objectives.
• Cross-Functional Leadership: Orchestrate a global/international, cross-functional team (Medical, Regulatory, Access, Commercial, Supply, etc.) to deliver seamless launch execution.
• Launch Readiness: Assess and drive readiness across core and priority markets, identifying risks and enabling mitigation plans to ensure timely launch execution.
• Insight Integration: Leverage market research, competitive intelligence, and stakeholder feedback to refine positioning, messaging, and tactical planning.
• International-Local Partnership: Partner closely with regional and country teams to ensure pull-through of global strategy, providing guidance and tools to support in-market success.
• Milestone Tracking & Governance: Define and track critical launch milestones and KPIs; lead governance updates and ensure timely decision-making across key forums.
• Stakeholder Engagement: Effectively communicate Remibrutinib’s vision and strategic goals to senior leaders, including the International Leadership Team (ILT), Country Presidents (CP), and regional heads.
• Compliance & Excellence: Uphold the highest standards of compliance and launch excellence throughout all activities.
• Collaborate closely with global development to influence target product profile & Integrated Evidence Plan to maximize commercialization & patient access potential for Remibrutinib new indications and LCM in key markets in international.

• Lead Remibrutinib International Commercialization Excellence (ICE) initiatives, driving best practices in customer engagement strategies. Foster a customer-centric mindset within the international and country teams, focusing on personalizing experiences to extend patient reach and commercial impact.

Essential requirements:

• +15 years of commercial experience across various functions in country(s) and above country, demonstrating a broad and deep understanding of the commercial landscape.
• Proven track record of successful launches, with commercial leadership experience and therapeutic area (TA) leadership in core markets.
• Extensive commercial experience in immunology, especially working with dermatologists/allergologist.
• Experience with high-performing/high-growth brands or markets, with a clear understanding of key drivers that influence shifting customer and patient behaviors to ensure successful asset launches.
• Proficient in translating scientific data into differentiated brand value propositions, enabling impactful launches across pre-launch through lifecycle management (LCM).
• Strong track record in collaborating and partnering with cross-unit, cross-functional & key markets to achieve strategic and performance targets.

Leadership Capabilities:

• Proven ability to manage and drive performance, ensuring targets are met and exceeded in challenging markets.
• Demonstrated ability to lead and inspire teams, drive cross-functional collaboration, and think strategically in dynamic environments.
• Focuses on larger, longer-term issues, and creates plans and strategies. Comfortable in navigating the matrix and people related organizational dynamics.
• Establish credibility & influence across diverse stakeholders and able to navigate in an environment of shared outcomes and cross-business accountabilities. Demonstrates enterprise leadership, balance diverse stakeholders and conflicting priorities to drive results.
• Empowered teams to execute efficiently, through the layers of organization and across geographies.
• Clearly and effectively communicates with senior stakeholders (both internal &external)– to align on vision, purpose & goals. Generates trust, builds credibility and drives engagement with people and stakeholders.

Skills Desired Asset Management, Asset Management, Business Development, Business Strategies, Commercial Excellence, Cross-Functional Work, Customer-Oriented, Digital Marketing, Go-to-Market Strategies, Healthcare Sector Understanding, Influencing Skills, Inspirational Leadership, Key Account Management, Market Access, Marketing Strategies, Market Share, Market Trend, Negotiation, People Management, Priority Disease Areas Expertise, Product Launches, Product Lifecycle Management (PLM), Product Positioning, Profit and Loss (P&L), Sales {+ 4 more}